FGIPX
Price
$15.12
Change
+$0.12 (+0.80%)
Updated
Jan 17 closing price
Net Assets
N/A
RMFCX
Price
$55.77
Change
+$0.30 (+0.54%)
Updated
Jan 17 closing price
Net Assets
102.85B
Ad is loading...

FGIPX vs RMFCX

Header iconFGIPX vs RMFCX Comparison
Open Charts FGIPX vs RMFCXBanner chart's image
Macquarie Growth and Income Instl
Price$15.12
Change+$0.12 (+0.80%)
VolumeN/A
Net AssetsN/A
American Funds American Mutual R3
Price$55.77
Change+$0.30 (+0.54%)
VolumeN/A
Net Assets102.85B
FGIPX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FGIPX vs. RMFCX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FGIPX is a StrongBuy and RMFCX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
FGIPX pays higher dividends than RMFCX: FGIPX (2.35) vs RMFCX (1.69). FGIPX was incepted earlier than RMFCX: FGIPX (12 years) vs RMFCX (23 years). FGIPX (26.00) and RMFCX (25.00) have comparable annual turnover. FGIPX has a lower initial minimum investment than RMFCX: FGIPX (0) vs RMFCX (250). RMFCX annual gain was more profitable for investors over the last year : 12.43 vs. FGIPX (10.60). RMFCX return over 5 years is better than : 37.82 vs. FGIPX (14.75).
FGIPXRMFCXFGIPX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence12 years23 years-
Gain YTD4.1322.162191%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net AssetsN/A103B-
Annual Yield % from dividends2.351.69139%
Returns for 1 year10.6012.4385%
Returns for 3 years10.2212.6081%
Returns for 5 years14.7537.8239%
Returns for 10 years-19.3765.18-30%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CDZI5.160.23
+4.77%
CADIZ
HOOD48.152.07
+4.49%
Robinhood Markets
NERV2.230.08
+3.72%
Minerva Neurosciences
WHD63.63-0.15
-0.24%
Cactus
EOLS10.51-0.10
-0.94%
Evolus